This trial is active, not recruiting.

Condition fabry disease in the young stroke
Treatment blood test
Sponsor Wolfson Medical Center
Start date May 2010
End date December 2014
Trial size 1000 participants
Trial identifier NCT01109875, 1


The purpose of this study is to determine the incidence of Fabry Disease in young stroke patients in an Israeli stroke clinic.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose diagnostic

Primary Outcomes

positive screening of fabry disease
time frame: past 5 years

Eligibility Criteria

Male or female participants from 18 years up to 55 years old.

Inclusion Criteria: diagnosis of stoke or TIA Time period within last 5 years - Exclusion Criteria: Known diagnosis of stroke or index event due to trauma -

Trial information was received from ClinicalTrials.gov and was last updated in June 2014.
Information provided to ClinicalTrials.gov by Wolfson Medical Center.